GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » 3-Year EPS without NRI Growth Rate

Panacea Biotec (BOM:531349) 3-Year EPS without NRI Growth Rate : 11.90% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec 3-Year EPS without NRI Growth Rate?

Panacea Biotec's EPS without NRI for the three months ended in Dec. 2023 was ₹-0.70.

During the past 3 years, the average EPS without NRI Growth Rate was 11.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Panacea Biotec was 64.50% per year. The lowest was -58.90% per year. And the median was 8.10% per year.


Competitive Comparison of Panacea Biotec's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Panacea Biotec's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's 3-Year EPS without NRI Growth Rate falls into.



Panacea Biotec 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Panacea Biotec  (BOM:531349) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Panacea Biotec 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec (BOM:531349) Business Description

Industry
Traded in Other Exchanges
Address
Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines